Comparison consequences of Jackson-Pratt drain versus chest tube after coronary artery bypass grafting: A randomized

Mohsen Mirmohammad-Sadeghi1, Pejman Pourazari1, Mojtaba Akbari2

  • 1Department of Cardiac Surgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Insights

The Jackson-Pratt drain is as effective as conventional chest tubes for preventing cardiac tamponade and pleural effusions after coronary artery bypass grafting (CABG). It also reduces hospital stay and atrial fibrillation incidence.

Area of Science:

  • Cardiovascular Surgery
  • Thoracic Surgery
  • Medical Devices

Background:

  • Chest tubes are standard post-coronary artery bypass grafting (CABG) to manage fluid and blood around the heart and lungs.
  • Conventional chest drains are widely used, but their effectiveness and patient impact warrant further investigation.

Purpose of the Study:

  • To compare the efficacy of Jackson-Pratt drains versus conventional chest tubes in patients undergoing CABG.
  • To assess outcomes including pleural effusions, pain, tamponade, atrial fibrillation, and length of stay.

Main Methods:

  • A randomized controlled trial involving 218 patients undergoing CABG.
  • Patients were randomized to receive either a Jackson-Pratt drain (n=109) or conventional double chest tubes (n=109).
  • Outcomes measured included pleural effusions, pain scores, cardiac tamponade, atrial fibrillation, and hospital/ICU length of stay.

Main Results:

  • No significant difference in the incidence of pleural effusions between the two groups.
  • Jackson-Pratt drain group showed significantly lower frequencies of cardiac tamponade and atrial fibrillation (AF).
  • Pain scores at 2 hours were higher in the Jackson-Pratt drain group, but the overall trend was not significantly different.

Conclusions:

  • Jackson-Pratt drains are equally effective as conventional chest tubes for preventing cardiac tamponade, pleural effusions, and managing pain intensity post-CABG.
  • Jackson-Pratt drains demonstrated superior efficacy in reducing hospital and Intensive Care Unit length of stay and the incidence of AF.
Abstract

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
424
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
553
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K